MUTATION ANALYSIS OF K-RAS ONCOGENES IN GASTROENTEROLOGIC CANCERS BY THE AMPLIFIED CREATED RESTRICTION SITES METHOD

被引:34
作者
LIN, SY
CHEN, PH
WANG, CK
LIU, JD
SIAUW, CP
CHEN, YJ
YANG, MJ
LIU, MH
CHEN, TC
CHANG, JG
机构
[1] TAIPEI MUNICIPAL JEN AI HOSP,DEPT MOLEC MED & CLIN PATHOL,MOLEC GASTROENTEROL SECT,10 SECT 4,TAIPEI,TAIWAN
[2] TAIPEI MUNICIPAL JEN AI HOSP,DEPT SURG,TAIPEI,TAIWAN
关键词
AMPLIFIED CREATED RESTRICTION SITE; DIRECT SEQUENCING; GASTROENTEROLOGIC CANCERS; MUTAGENESIS PRIMER; POLYMERASE CHAIN REACTION; RAS ONCOGENE; RESTRICTION ENZYME;
D O I
10.1093/ajcp/100.6.686
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A rapid, simple, and nonradioactive method for diagnosing point mutations of c-K-ras oncogenes in gastroenterologic cancers is described. This method involved the selective amplification of DNA fragments from cancer tissues of surgical specimens with specific oligonucleotide primers, followed by digestion with restriction enzymes that recognized artificially created or naturally occurring restriction sites. To detect codon 12 mutations, an artificial Msp I site was created by introducing a single nucleotide mismatch into the 5' mutagenesis primer. Using a similar approach, an Hae III site was created to detect codon 13 mutations. Bal I and MBo II sites were used to detect codon 61 mutations. A total of 61 gastroenterologic cancer cases were studied. Of 35 cases of colorectal cancer, 7 showed mutations: 6 at codon 12 and 1 at codon 13. In 1 of 2 cases of cholangiocellular carcinoma, point mutation at codon 12 was found. One case of duodenal cancer showed point mutation at codon 12. No mutations were found in the cases of hepatocellular carcinoma (4), gastric cancer (12), esophageal cancer (3), or pancreatic cancer (2).
引用
收藏
页码:686 / 689
页数:4
相关论文
共 25 条
[1]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[2]   PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS [J].
BOS, JL ;
FEARON, ER ;
HAMILTON, SR ;
VERLAANDEVRIES, M ;
VANBOOM, JH ;
VANDEREB, AJ ;
VOGELSTEIN, B .
NATURE, 1987, 327 (6120) :293-297
[3]  
BOS JL, 1988, MUTAT RES, V195, P259
[4]  
CHANG JG, 1992, BLOOD, V80, P1079
[5]   CELLULAR TRANSFORMING GENES [J].
COOPER, GM .
SCIENCE, 1982, 217 (4562) :801-806
[6]   DETECTION OF RAS POINT MUTATIONS BY POLYMERASE CHAIN-REACTION USING MUTATION-SPECIFIC, INOSINE-CONTAINING OLIGONUCLEOTIDE PRIMERS [J].
EHLEN, T ;
DUBEAU, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :441-447
[7]   APPLICATION OF NATURAL AND AMPLIFICATION CREATED RESTRICTION SITES FOR THE DIAGNOSIS OF PKU MUTATIONS [J].
EIKEN, HG ;
ODLAND, E ;
BOMAN, H ;
SKJELKVALE, L ;
ENGEBRETSEN, LF ;
APOLD, J .
NUCLEIC ACIDS RESEARCH, 1991, 19 (07) :1427-1430
[8]   DETECTION OF HIGH-INCIDENCE OF K-RAS ONCOGENES DURING HUMAN-COLON TUMORIGENESIS [J].
FORRESTER, K ;
ALMOGUERA, C ;
HAN, KY ;
GRIZZLE, WE ;
PERUCHO, M .
NATURE, 1987, 327 (6120) :298-303
[9]   MODIFICATION OF ENZYMATICALLY AMPLIFIED DNA FOR THE DETECTION OF POINT MUTATIONS [J].
HALIASSOS, A ;
CHOMEL, JC ;
TESSON, L ;
BAUDIS, M ;
KRUH, J ;
KAPLAN, JC ;
KITZIS, A .
NUCLEIC ACIDS RESEARCH, 1989, 17 (09) :3606-3606
[10]  
JIANG W, 1989, ONCOGENE, V4, P923